1-7 of 7
Adam Olshen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Multiomic Single-Cell Sequencing of Mixed Phenotypic Acute Leukemia (MPAL) Reveals Complex Immunophenotypic, Transcriptional, and Genetic Heterogeneity

Cheryl Peretz, Vanessa E. Kennedy, Anushka Walia, Cyrille Delley, Andrew Koh, Elaine Tran, Iain Clark, Corey Hayford, Yi Xue, Chris D'Amato, Kristina Fontanez, Ritu P. Roy, Adam Olshen, Aaron C. Logan, Alexander E. Perl, Adam Abate, Catherine Smith
Journal: Blood
Blood (2022) 140 (Supplement 1): 9146–9147.
https://doi.org/10.1182/blood-2022-167860
Published: 2022
Journal Articles

Heterogeneous resistance to quizartinib in acute myeloid leukemia revealed by single-cell analysis

Catherine C. Smith, Amy Paguirigan, Grace R. Jeschke, Kimberly C. Lin, Evan Massi, Theodore Tarver, Chen-Shan Chin, Saurabh Asthana, Adam Olshen, Kevin J. Travers, Susana Wang, Mark J. Levis, Alexander E. Perl, Jerald P. Radich, Neil P. Shah
Journal: Blood
Blood (2017) 130 (1): 48–58.
https://doi.org/10.1182/blood-2016-04-711820
Published: 2017
Includes: Supplemental data
Journal Articles

CD32B Expression Reflects Phenotypic and Functional Heterogeneity in Multiple Myeloma (MM)

Ping Zhou, MD, PhD, Adam M Boruchov, MD, James E. Hoffman, MD, Qianxing Mo, Adam Olshen, Evan Glasner, Ezio Bonvini, Scott Koenig, Ellen Drieghe, Martin Fleisher, PhD, Peter Maslak, MD, Hani Hassoun, MD, Adam D Cohen, MD, Heather Landau, MD, James W. Young, MD, Suresh C Jhanwar, PhD, Stephen D Nimer, MD, Raymond L Comenzo
Journal: Blood
Blood (2008) 112 (11): 842.
https://doi.org/10.1182/blood.V112.11.842.842
Published: 2008
Journal Articles

Molecular Responses to Dasatinib and Nilotinib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP).

Alfonso QuintαsCardama, Hagop Kantarjian, Franziska Michor, Adam Olshen, Mithat Gonen, Dan Jones, Mary Beth Rios, Susan O’Brien, Jorge Cortes, MD
Journal: Blood
Blood (2008) 112 (11): 3244.
https://doi.org/10.1182/blood.V112.11.3244.3244
Published: 2008
Journal Articles

Modelling BCR-ABL1 Dynamics in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) during Frontline Therapy with High-Dose Imatinib, Nilotinib, or Dasatinib.

Adam Olshen, Alfonso Quintαs-Cardama, Hagop M. Kantarjian, Mithat Gonen, Franziska Michor, Jorge Cortes, MD
Journal: Blood
Blood (2008) 112 (11): 3240.
https://doi.org/10.1182/blood.V112.11.3240.3240
Published: 2008
Journal Articles

Calreticulin expression in the clonal plasma cells of patients with systemic light-chain (AL-) amyloidosis is associated with response to high-dose melphalan

Clinical Trials & Observations
Ping Zhou, Julie Teruya-Feldstein, Ping Lu, Martin Fleisher, Adam Olshen, Raymond L Comenzo
Journal: Blood
Blood (2008) 111 (2): 549–557.
https://doi.org/10.1182/blood-2007-05-090852
Published: 2008
Journal Articles

Cell of origin, germinal center versus nongerminal center, determined by immunohistochemistry on tissue microarray, does not correlate with outcome in patients with relapsed and refractory DLBCL

Clinical Trials & Observations Brief Report
Craig H. Moskowitz, Andrew D. Zelenetz, Tarun Kewalramani, Paul Hamlin, Simone Lessac-Chenen, Jane Houldsworth, Adam Olshen, Raju Chaganti, Stephen Nimer, Julie Teruya-Feldstein
Journal: Blood
Blood (2005) 106 (10): 3383–3385.
https://doi.org/10.1182/blood-2005-04-1603
Published: 2005